Clinical Trial Update: A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment

View source ↗

Summary

Ipsen is conducting a clinical study to observe the everyday effectiveness and safety of Elafibranor in participants with Primary Biliary Cholangitis who are re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Elafibranor

Snippet

Sponsor: Ipsen | Conditions: Primary Biliary Cholangitis | Status: RECRUITING